Many current treatments for chronic pain, such as opioids, have significant side effects and potential for abuse. An NTS1-based approach could provide safer and more effective options ...
Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...
Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable ...